Skip to main content
. Author manuscript; available in PMC: 2014 Jan 31.
Published in final edited form as: Clin Cancer Res. 2010 May 18;16(11):3067–3077. doi: 10.1158/1078-0432.CCR-10-0054

Fig. 2.

Fig. 2

Pretreatment and posttreatment computed tomography imaging data for target (A and B) and nontarget (C and D) lesions of patient 0101. A and B, pretreatment and posttreatment imaging of left supraclavicular fossa mass (red arrows) showing significant volume reduction maintained at 7 months (B). C, D, pre- and posttreatment imaging of mediastinal disease (white arrows) showing a maintained response at 7 months (D). E, Vitiligo arising in the irradiated field of patient 0602. Note the sharp demarcation between the normal pigmentation in the hair-bearing skin and the depigmented, nonhearing bearing skin at the superior border of the radiation field (black arrow). Focal loss of hair pigmentation is also seen (white arrows).